What question did this study set out to answer?

To determine if combining ixekizumab with tirzepatide provides better disease control in adults with psoriatic arthritis and obesity.

June 13, 2026Open Access

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity

Key Points

To determine if combining ixekizumab with tirzepatide provides better disease control in adults with psoriatic arthritis and obesity.
Randomized trial comparing ixekizumab plus tirzepatide vs. ixekizumab alone
Population included adults with psoriatic arthritis and overweight or obesity
Significant improvement in disease control was observed with ixekizumab plus tirzepatide compared to ixekizumab alone.

Abstract

Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity

Key Points

Abstract

Cite This Study

Also Consider

Also Consider